Monitor for actual sales near the January 12, 2026 date; since this is under a pre-established 10b5-1 plan, it carries less negative signal than an ad-hoc sale, but traders should still watch for execution as it may coincide with other catalysts.
Price Chart
Executive Summary
Nagendran Sukumar, an officer of Taysha Gene Therapies, filed a Form 144 to notify intent to sell up to 200,000 shares of common stock, valued at approximately $942,740, under a 10b5-1 selling plan adopted on June 11, 2025. The sale is scheduled for January 12, 2026.
Key Facts
- Reporting person: Nagendran Sukumar, officer of TSHA
- Number of shares proposed for sale: 200,000
- Approximate value of shares: $942,740
- Sale date: January 12, 2026
- Sales to be executed under a 10b5-1 plan adopted on June 11, 2025
- Shares are common stock issued from prior RSU and stock option grants
Financial Impact
Approximately $942,740 in potential near-term selling pressure from an insider, representing a small fraction of TSHA's $1.3B market cap.
Risk Factors
- Potential perception of insider selling ahead of earnings or clinical trial readouts
- Execution of sale could contribute to short-term downward price pressure if market conditions are weak
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001974158-26-000040 |
| Document: 0001974158-26-000040-index.html | 0001974158-26-000040 |
| Document: 0001974158-26-000040.txt | 0001974158-26-000040 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Press Release | $6.41 $5.16 | ▼ −19.44% | ▼ −17.54% | $4.63 (−27.71%) |
Jun 25, 2026 14w ago | 8-K | $6.34 $5.83 | ▼ −8.04% | ▼ −9.30% | $4.63 (−26.97%) |
Jun 25, 2026 14w ago | 424B5 | $6.34 $5.83 | ▲ +8.04% | ▲ +9.30% | $4.63 (+26.97%) |
Jun 25, 2026 14w ago | Press Release | $6.21 $5.83 | ▲ +6.12% | ▲ +6.65% | $4.63 (+25.44%) |
Jun 5, 2026 17w ago | Press Release | $5.50 $6.38 | ▲ +16.00% | ▲ +14.14% | $4.63 (−15.82%) |
May 6, 2026 21w ago | 8-K | $6.98 $5.55 | ▼ −20.49% | ▼ −23.27% | $4.63 (−33.67%) |
May 6, 2026 21w ago | Press Release | $6.98 $5.55 | ▼ −20.49% | ▼ −23.27% | $4.63 (−33.67%) |
Apr 29, 2026 22w ago | Press Release | $6.27 $5.75 | ▼ −8.29% | ▼ −13.75% | $4.63 (−26.16%) |
Apr 27, 2026 22w ago | Press Release | $6.30 $5.59 | ▼ −11.27% | ▼ −16.74% | $4.63 (−26.51%) |
Apr 22, 2026 23w ago | DEFA14A | $6.72 $5.19 | ▼ −22.84% | ▼ −26.01% | $4.63 (−31.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access